Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor α Promoter Region and in Lymphotoxin α in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer

Translational Oncology

Volumn 4, Issue 6, 2011, Pages 336-344

  Nieves Ramirez, Miriam Enriqueta ^a   Partida Rodriguez, Oswaldo ^a   Alegre Crespo, Pedro Eduardo ^b   Tapia Lugo, Maria del Carmen ^b   Perez Rodriguez, Martha Esthela ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LYMPHOTOXIN; OLIGONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MEXICO; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 82855176762     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11226     Document Type: Article

References (62)

1. Palacio-Mejia LS, Rangel-Gomez G, Hernández-Avila M, and Lazcano-Ponce E (2003). Cervical cancer, a disease of poverty: mortality differences between urban and rural area in Mexico. Salud Publica Mex 45, S315-S325.
2. Münger K, Baldwin A, Edwards MK, Hayakawa H, Nguyen LC, Owens M, Grace M, and Huh WK (2004). Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78, 11451-11460.
3. Fernandez AM, Gonçalves GM, Duarte G, Cunha QF, Simoes TR, and Danadi AE (2005). HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology 334, 294-298.
4. Zheng ZM and Baker CC (2006). Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11, 2286-2302.
5. zur Hausen H (2002). Papillomaviruses and cancer. From basic studies to clinical application. Nat Rev Cancer 2, 342-350.
6. Beglin M, Melar-New M, and Laimins L (2009). Human papillomaviruses and the interferon response. J Interferon Cytokine Res 29, 629-635.
7. Sharma A, Rajappa M, Satyam A, and Sharma M (2009). Cytokines (TH1 and TH2) in patients with advanced cervical cancer undergoing neoadjuvant chemoradiation: correlation with treatment response. Int J Gynecol Cancer 19, 1269-1275.
8. Gangwar R, Pandey S, and Mittal RD (2009). Association of interferon-γ +874 polymorphism with the risk of developing cervical cancer in north-Indian population. BJOG 116, 1671-1777.
9. Hohaus S, Giachelia M, Di Febo A, Martini M, Massini G, Vannata B, D'Alo F, Guidi F, Greco M, Pierconti F, et al. (2007). Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Ann Oncol 18, 1376-1381.
10. Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F, and Rihet P (2005). TNF as a malaria candidate gene: polymorphism-screening and familybased association analysis of mild malaria attack and parasitemia in Burkina Faso. Genes Immun 6, 472-480.
11. Tomasdottir H, Hjartarson H, Ricksten A, Wasslavik C, Bengtsson A, and Ricksten SE (2003). Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 97, 944-949.
12. Messer G, Spengler U, JungMC, Honold G, Blömer K, Pape GR, Riethmüller G, and Weiss EH (1991). Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 173, 209-218.
13. Yoon JK, Hyo-Suk L, Jung-Hwan Y, Chung YK, Myoung HP, Lyoung HK, Byung LP, and Hyoung DS (2003). Association of TNF-α promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 12, 2541-2546.
14. Berek SJ (2003). Simplification of the New Bethesda 2001. Classification System. Am J Obstet Gynecol 188, S3-S5.
15. Miller SA, Dykes KK, and Plesky HF (1988). A single salting out procedure for extracting DNA from human nucleated cell. Nucleic Acid Res 16, 1215.
16. Sepp R, Szabú I, Uda H, and Sakamoto H (1994). Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 43, 318-323.
17. Manos M, Ting M, Wright D, Lewis A, Broker T, and Wolinsky S (1989). Use polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7, 209-214.
18. De Roda AM, Walboomers JMM, Van Den Brule AJC, Meijer CJ, and Snijders PJ (1995). The use of the general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76, 1057-1062.
19. Meissner JD (1999). Nuecleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80, 1725-1733.
20. Wilson GA, Symons AJ, McDowell LT, McDevitt OH, and Duff WG (1997). Effects of a polymorphism in the human tumor necrosis α promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199.
21. Niizeki H, Narose T, Hashigucci K, Yokoyama M, Yamasaki Y, Akiya K, Tojo T, Urushibara T, Yamazaki Y, Inoko H, et al. (2000). Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis. Tissue Antigens 56, 162-165.
22. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, and Itoh K (1998). Polymorphism of the 5' flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 51, 605-612.
23. Endo M, Tai H, Tabeta K, Kobayashi T, Yamazaki K, and Yoshie H (2001). Analysis of single nucleotide polymorphisms in the 5' flanking region of tumor necrosis factor-α gene in Japanese patients with early-onset periodontitis. J Periodontol 72, 1554-1559.
24. Marsh SGE, Packer R, Heyes JM, Bolton B, Fauchet R, Charron D, and Bodmer JG (1997). The 12th International Histocompatibility Workshop Cell Lines Panel. In HLA: Genetic Diversity of HLA Functional and Medical Implications. D Charron (Ed). EDK, Paris, France. pp. 26-28.
25. Yamaguchi E, Itoh A, Hizawa N, and Kawakami Y (2001). The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis. Chest 119, 753-761.
26. Matthews DE and Farewell V (1985). Using and Understanding Medical Statistics. Karger, New York, NY. p. 39.
27. Hervada VX, Santiago PM, Vazquez FE, Castillo SC, Loyola E, and Silva ALC (2004). Epidat 3.0 Programa para análisis epidemiológico de datos tabulados. Rev Esp Salud Pública 78, 277-280.
28. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC, et al. (2005). G-308A TNFα polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334, 588-592.
29. Barrett JC, Fry B, Maller J, and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
30. Kay P, Soeters R, Nevin J, Denny L, Dehaeck MC, and Wiliamson AL (2003). High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 71, 265-273.
31. Xi FL, Touré P, Critchlow WC, Hawes ES, Dembele B, Sow SP, and Kiviat BN (2003). Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 103, 803-809.
32. Watt A, Garwood D, Jackson M, Younger N, Ragin C, Smikle M, Fletcher H, and McFarlane-Anderson N (2009). High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. Infect Agent Cancer 4(Suppl 1), S11.
33. González-Losa M, Rosado-Lopéz I, Valdez-González N, and Puerto-Solis M (2004). High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 29, 202-205.
34. Aguirre HR, Medina CL, Montoya FH, Sandoval LG, Padilla RM, García SV, and Jáuregui MA (2007). Factores relacionados con el cáncer cervicouterino en el estado de Nayarit, Mexico. Ginecol Obstet Mex 75, 311-316.
35. Liu C, Wang J, Zhou S, Wang B, and Ma X (2010). Association between-238 but not-308 polymorphism of tumor necrosis factor α (TNF. α)v and unexplained recurrent spontaneous abortion (URSA) in Chinese population. Reprod Biol Endocrinol 8, 114.
36. Partida-Rodríguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramírez M, Lazcano E, and Pérez-Rodríguez M (2010). Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer. Int J Cancer 126, 1861-1868.
37. Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, and Persing DH (2002). Host genetic polymorphism analysis in cervical cancer. Clin Chem 48, 1218-1224.
38. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, and Wheeler CM(2005). TNFα promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 15, 969-976.
39. Merza M, Farnia P, Anoosheh S, Varahram M, Kazampour M, Pajand O, Saeif S, Mirsaeidi M, Masjedi MR, Velayati AA, et al. (2009). The NRAMPI, VDR and TNFα gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility. Braz J Infect Dis 13, 252-256.
40. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quiñones-Berrocal J, Fraser PA, Uko GP, Delgado JC, ClavijoOP, et al. (2002). TNFα promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 3, 482-487.
41. Kirkpatrick A, Bidwell J, van den Brule AJC, Meijer CJLM, Pawade J, and Glew S (2004). TNFα polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92, 675-679.
42. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, and Bharadwaj M (2007). TNFα-308 G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29, 249-256.
43. Ivansson EL, Magnusson JJ, Magnusson PKE, Erlich HA, and Gyllensten UB (2008). MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes Immun 9, 613-623.
44. Zuñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, and Granados J (2001). Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2, 363-366.
45. Azmy IA, Balasubramanian SP, Wilson GA, Stephenson JT, Cox A, Brown JN, and Reed WM (2004). Role of tumour necrosis factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res 6, R395-R400.
46. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, and Paik KH (2001). The-238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166, 41-46.
47. Singh H, Jain M, Sachan R, and Mittal B (2009). Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 19, 1190-1194.
48. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, and Kwiatkowski D (1999). A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22, 145-150.
49. Wu GD, Lai EJ, Huang N, and Wen X (1997). Oct-1 and CCAAT/enhancer binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J Biol Chem 272, 2396-2403.
50. Yamashina M, Kaneko Y, Maesawa C, Kajiwara T, Ishii M, Fujiwara F, Taneichi H, Takebe N, Ishida W, Takahashi K, et al. (2007). Association of TNF-α gene promoter C-857T polymorphism with higher serumLDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes. Tohoku J Exp Med 211, 251-258.
51. Hohjoh H and Tokunaga K (2001). Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-α gene (TNFA) promoter. Genes Immun 2, 105-109.
52. Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK, Liyanage S, du Bois RM, Welsh KI, and Lightman S (2005). TNF-857, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 46, 1565-1571.
53. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, and Kwiatkowski D (2000). Functional consequences of a polymorphism affecting NF-κB p50-p50 binding to the TNF promotor region. Mol Cell Biol 20, 9113-9119.
54. Kang CP, Lee KW, Yoo DH, Kang C, and Bae SC (2005). The influence of a polymorphism at position-857 of the tumour necrosis factor α gene on clinical response to entenercept therapy in rheumatoid arthritis. Rheumatology 44, 547-552.
55. Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, and Maruo T (2004). The tumor necrosis factor-α promoter-1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 19, 2509-2514.
56. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, and Toyota T (1999). Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology 117, 1062-1068.
57. Gyoung HL, YoungMC, Sung HK, Min AH, Sung TO, Young TL, and Shin YM (2008). Association of tumor necrosis factor-α gene polymorphisms with advanced stage endometriosis. Hum Reprod 23, 977-981.
58. Yi-Chun C, Fen-Ju H, Phoebe C, Yih-Ru W, Hsiu-Chuan W, Sien-Tsong C, Guey-Jen Lee C, and Chiung-Mei C (2010). Association of TNFα gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study. BMC Neurol 10, 41.
59. Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, Rubertone MV, Erickson RL, and McGlynn KA (2007). A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 16, 77-83.
60. Tanaka G, Sandford AJ, Burkett K, Connett JE, Anthonisen NR, Paré PD, and He JQ (2007). Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 29, 34-41.
61. Sharma S, Rathored J, Ghosh B, and Sharma KS (2010). Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis 10, 165.
62. Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, and Hamajima N (2005). Lymphotoxin-α polymorphism and the risk of cervical cancer in Japanese subjects. Cancer Lett 218, 63-68.